245 related articles for article (PubMed ID: 9727009)
1. Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha.
de Moissac D; Mustapha S; Greenberg AH; Kirshenbaum LA
J Biol Chem; 1998 Sep; 273(37):23946-51. PubMed ID: 9727009
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 intersects the NFkappaB signalling pathway and suppresses apoptosis in ventricular myocytes.
Kirshenbaum LA
Clin Invest Med; 2000 Oct; 23(5):322-30. PubMed ID: 11055326
[TBL] [Abstract][Full Text] [Related]
3. Linkage of the BH4 domain of Bcl-2 and the nuclear factor kappaB signaling pathway for suppression of apoptosis.
de Moissac D; Zheng H; Kirshenbaum LA
J Biol Chem; 1999 Oct; 274(41):29505-9. PubMed ID: 10506215
[TBL] [Abstract][Full Text] [Related]
4. Activation of nuclear factor kappaB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IkappaBalpha.
Bui NT; Livolsi A; Peyron JF; Prehn JH
J Cell Biol; 2001 Feb; 152(4):753-64. PubMed ID: 11266466
[TBL] [Abstract][Full Text] [Related]
5. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha.
Mukhopadhyay A; Manna SK; Aggarwal BB
J Biol Chem; 2000 Mar; 275(12):8549-55. PubMed ID: 10722693
[TBL] [Abstract][Full Text] [Related]
6. IKK beta is required for Bcl-2-mediated NF-kappa B activation in ventricular myocytes.
Regula KM; Ens K; Kirshenbaum LA
J Biol Chem; 2002 Oct; 277(41):38676-82. PubMed ID: 12167626
[TBL] [Abstract][Full Text] [Related]
7. A direct requirement of nuclear factor-kappa B for suppression of apoptosis in ventricular myocytes.
Mustapha S; Kirshner A; De Moissac D; Kirshenbaum LA
Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H939-45. PubMed ID: 10993753
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.
Han Y; Weinman S; Boldogh I; Walker RK; Brasier AR
J Biol Chem; 1999 Jan; 274(2):787-94. PubMed ID: 9873017
[TBL] [Abstract][Full Text] [Related]
9. Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo.
Roff M; Thompson J; Rodriguez MS; Jacque JM; Baleux F; Arenzana-Seisdedos F; Hay RT
J Biol Chem; 1996 Mar; 271(13):7844-50. PubMed ID: 8631829
[TBL] [Abstract][Full Text] [Related]
10. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms.
Li N; Karin M
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13012-7. PubMed ID: 9789032
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin stress-response in cardiomyocytes: NF-kappaB activation and tumor necrosis factor-alpha expression.
Wright G; Singh IS; Hasday JD; Farrance IK; Hall G; Cross AS; Rogers TB
Am J Physiol Heart Circ Physiol; 2002 Mar; 282(3):H872-9. PubMed ID: 11834481
[TBL] [Abstract][Full Text] [Related]
12. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
[TBL] [Abstract][Full Text] [Related]
13. Effect of NF-kappa B Inhibition on TNF-alpha-induced apoptosis and downstream pathways in cardiomyocytes.
Bergmann MW; Loser P; Dietz R; von Harsdorf R
J Mol Cell Cardiol; 2001 Jun; 33(6):1223-32. PubMed ID: 11444925
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor.
Hellerbrand C; Jobin C; Iimuro Y; Licato L; Sartor RB; Brenner DA
Hepatology; 1998 May; 27(5):1285-95. PubMed ID: 9581682
[TBL] [Abstract][Full Text] [Related]
15. A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells.
Shumway SD; Miyamoto S
Biochem J; 2004 May; 380(Pt 1):173-80. PubMed ID: 14763901
[TBL] [Abstract][Full Text] [Related]
16. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
[TBL] [Abstract][Full Text] [Related]
17. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
Roussel RR; Barchowsky A
Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest.
Hu X; Bryington M; Fisher AB; Liang X; Zhang X; Cui D; Datta I; Zuckerman KS
J Biol Chem; 2002 May; 277(19):16528-37. PubMed ID: 11864973
[TBL] [Abstract][Full Text] [Related]
19. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.
Desterro JM; Rodriguez MS; Hay RT
Mol Cell; 1998 Aug; 2(2):233-9. PubMed ID: 9734360
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma.
Bu R; Hussain AR; Al-Obaisi KA; Ahmed M; Uddin S; Al-Kuraya KS
Leuk Lymphoma; 2014 Feb; 55(2):415-24. PubMed ID: 23697845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
